CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing Emeramide, a safe and effective iron chelator for patients with β-thalassemia major. It aims to improve patient compliance and quality of life by reducing iron overload from frequent blood transfusions, thus addressing a critical health need.
β-thalassemia major (βTM) is a lethal orphan disease with genetic background, diagnosed in infancy and requiring recurrent blood transfusions to prevent malformations, assure acceptable quality of life and prolong patient’s lifetime.
Constant transfusions are related to severe adverse effects due to the resultant iron overload, including severe impairment of internal organs’ function and heart disease, with cardiac complications causing over two thirds of deaths in βTM patients.
Life-long, effec…
NBMI SCIENCE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
